SANSROSA PHARMACEUTICALS
Sansrosa Pharmaceutical Development, researches and develops dermatological products for the treatment of rosacea.
SANSROSA PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Conshohocken, Pennsylvania, United States
Country:
United States
Status:
Active
Total Funding:
500 K USD
Similar Organizations
Coria Laboratories
Develops dermatology pharmaceutical products .
Cyan Bio
Cyan Bio operates in the Biological Products.
Felema
Felema provides eco-friendly biological products.
Marillion Pharmaceuticals
Develops and commercializes pharmaceuticals.
Investors List
BioAdvance
BioAdvance investment in Seed Round - SansRosa Pharmaceuticals
BioAdvance
BioAdvance investment in Venture Round - SansRosa Pharmaceuticals
More informations about "SansRosa Pharmaceuticals"
SansRosa Pharmaceutical Development - PitchBook
May 27, 2003 SansRosa Pharmaceutical Development was acquired by CollaGenex Pharmaceuticals. Data Transparency. Meet our data hygiene team. Discover how our experts โฆSee details»
SansRosa Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... Seed Round - SansRosa Pharmaceuticals โ โฆSee details»
SansRosa Pharmaceutical Development, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SansRosa Pharmaceutical Development, Inc. of Fort Worth, TX. Get the latest business insights from โฆSee details»
SansRosa Pharmaceutical Development Inc Company Profile
As of December 14, 2005, SansRosa Pharmaceutical Development Inc. is a subsidiary of CollaGenex Pharmaceuticals Inc. digitGaps report on SansRosa Pharmaceutical Development โฆSee details»
Sansrosa Pharmaceutical Development, Inc. - Corporation Wiki
Apr 30, 2014 Sansrosa Pharmaceutical Development, Inc. Overview. Sansrosa Pharmaceutical Development, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on โฆSee details»
Seed Round - SansRosa Pharmaceuticals - 2005-02-25 - Crunchbase
Organization Name . SansRosa Pharmaceuticals . Announced Date Feb 25, 2005; Funding Type Seed; Funding Stage ...See details»
SansRosa Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Last update 10 Oct 2024. SansRosa Pharmaceuticals. Private Company |See details»
SansRosa Pharmaceutical Development, Inc. - Drug pipelines, โฆ
Last update 01 Nov 2024. SansRosa Pharmaceutical Development, Inc. Subsidiary Company |See details»
SansRosa Pharmaceutical Development Inc.
SansRosa, a Philadelphia-area start-up focused on dermatological conditions, is reprofiling a group of alpha agonists for use as treatments for rosacea and other disorders. The firm was โฆSee details»
The History of Sansrosa - The Rosacea Forum
Nov 19, 2007 SansRosa Pharmaceutical Development Inc was a company founded in 2003, simply to develop this product. They operated in the Philadelphia area and were bought by, โฆSee details»
SansRosa Pharmaceutical Development Inc - Company Profile and โฆ
Company profile page for SansRosa Pharmaceutical Development Inc including stock price, company news, executives, board members, and contact informationSee details»
SansRosa Pharmaceuticals - Crunchbase
Develops dermatological products.See details»
SANSROSA PHARMACEUTICAL DEVELOPMENT, INC - Company โฆ
On any company or organization. ... SANSROSA PHARMACEUTICAL DEVELO... SANSROSA PHARMACEUTICAL DEVELOPMENT, INC. Company Profile. Registration: Oct 9, 2003. State โฆSee details»
General
Explore SansRosa Pharmaceuticals profile on Finallot for insights on its team, products, and industry - Sansrosa Pharmaceutical Development is a company that focuses on developing โฆSee details»
Sansrosa - Rosacea Support Group
Sansrosa was the original name for the company and product based on the active ingredient in Alphangan P, brimonidine tartrate, used topically to relieve the red face of rosacea. Since โฆSee details»
SansRosa Pharmaceutical Development, Inc. (SansRosa โฆ
ไบ่งฃSansRosa Pharmaceutical Development, Inc. (SansRosa Pharmaceutical Development, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
Sansrosa and Afrin Updates from Dr. Fowler & Dr. Webster
Skin and Allergy News is running an article dated this week based on some informal comments from Dr. Joseph F. Fowler Jr. and Dr. Guy W. Webster given recently at the Hawaii โฆSee details»
Brimonidine topical gel - Galderma - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»
New rosacea treatments offer hope - Dermatology Times
Aug 1, 2005 Several new topicals will become available, including SR101, which SansRosa Pharmaceuticals has developed to reduce triggers and to treat rosacea redness and flushing. โฆSee details»